Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Androgens can both increase body hair and cause scalp hair loss.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Finasteride may effectively treat hair loss in Klinefelter Syndrome patients.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Substance from human umbilical cord blood cells promotes hair growth.